Opportunities for Consumer Research from the Food and Drug Administration's Center for Tobacco Products

被引:15
|
作者
Andrews, J. Craig [1 ]
Choiniere, Conrad J. [2 ]
Portnoy, David B.
机构
[1] Marquette Univ, Mkt, Milwaukee, WI 53233 USA
[2] Ctr Tobacco Prod Food & Drug Adm, Div Populat Hlth Sci, Off Sci, Rockville, MD 20857 USA
关键词
Food and Drug Administration; tobacco; consumer research; warnings; new and emerging products; CIGARETTE WARNING LABELS; HEALTH WARNINGS; PERCEIVED EFFECTIVENESS; UNITED-STATES; SMOKING; IMPACT; ADVERTISEMENTS; YOUTH; BEHAVIOR; SMOKERS;
D O I
10.1509/jppm.15.029
中图分类号
F [经济];
学科分类号
02 ;
摘要
The first purpose of this Policy Watch article is to discuss the Food and Drug Administration regulatory authority over the manufacture, marketing, and distribution of tobacco products. In doing so, the authors describe the public health goals and priorities from the Food and Drug Administration's Center for Tobacco Products. Then, the authors present current consumer and marketing research in important areas of reducing the death and disability resulting from tobacco use, such as the impacts of health warnings, modified risk tobacco products, new tobacco products, and public education campaigns. Finally, the authors identify important research gaps and offer specific opportunities for consumer researchers to consider.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 50 条
  • [21] Tobacco Advertising and Sales Practices in Licensed Retail Outlets After the Food and Drug Administration Regulations
    Ryan G. Frick
    Elizabeth G. Klein
    Amy K. Ferketich
    Mary Ellen Wewers
    Journal of Community Health, 2012, 37 : 963 - 967
  • [22] Estimating the Impact of Food and Drug Administration's Unapproved Drug Initiative on Drug Prices and Sales
    Sharma, Dolly
    Schumock, Glen T.
    Saffore, Christopher D.
    Edwards, S.
    Walton, Surrey M.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 424 - 430
  • [23] Food Origin Traceability from a Consumer's Perspective
    Walaszczyk, Anna
    Galinska, Barbara
    SUSTAINABILITY, 2020, 12 (05)
  • [24] Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration
    Yousefi, Nazila
    Moradi, Najmeh
    Dinarvand, Rassoul
    Ghiasi, Golbarg
    Inanloo, Hamidreza
    Peiravian, Farzad
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 27 (01) : 169 - 177
  • [25] Working with the US Food and Drug Administration to obtain approval of products under the Animal Rule
    Park, Glen D.
    Mitchel, Jules T.
    COUNTERMEASURES AGAINST CHEMICAL THREATS, 2016, 1374 : 10 - 16
  • [26] Overview of high-risk Food and Drug Administration recalls for cosmetics and personal care products from 2002 to 2016
    Janetos, Timothy M.
    Akintilo, Lisa
    Xu, Shuai
    JOURNAL OF COSMETIC DERMATOLOGY, 2019, 18 (05) : 1361 - 1365
  • [27] Tobacco Control 1 Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its future
    Husten, Corinne G.
    Deyton, Lawrence R.
    LANCET, 2013, 381 (9877) : 1570 - 1580
  • [28] The Nutrition Facts Label - U.S. Food and Drug Administration
    Beckwell, Jillian
    JOURNAL OF CONSUMER HEALTH ON THE INTERNET, 2025, 29 (01) : 86 - 100
  • [29] The signaling effects of incremental information: Evidence from stacked US Food and Drug Administration designations
    Miller, Kathleen L.
    Nardinelli, Clark
    Pink, George
    Reiter, Kristin
    QUARTERLY REVIEW OF ECONOMICS AND FINANCE, 2018, 67 : 219 - 226
  • [30] Health Literacy as Controversy: An Online Community's Discussion of the US Food and Drug Administration Acetaminophen Recommendations
    Mackert, Michael
    Love, Brad
    Donovan-Kicken, Erin
    Uhle, Katharine A.
    QUALITATIVE HEALTH RESEARCH, 2011, 21 (12) : 1607 - 1617